Outcome of Stroke With Mild or Rapidly Improving Symptoms
暂无分享,去创建一个
G. Schroth | H. Mattle | L. Remonda | J. Gralla | M. Arnold | U. Fischer | K. Nedeltchev | C. Brekenfeld | T. Haefeli | B. Schwegler | Tobias Haefeli
[1] G. Schroth,et al. Reasons to withhold intra-arterial thrombolysis in clinical practice , 2006, Journal of Neurology.
[2] Jeffery R. Alger,et al. Early MRI and outcomes of untreated patients with mild or improving ischemic stroke , 2006, Neurology.
[3] A. Siegel,et al. Good Outcomes in Ischemic Stroke Patients Treated With Intravenous Thrombolysis Despite Regressing Neurological Symptoms , 2006, Stroke.
[4] Steven Warach,et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): Evidence of Safety and Efficacy 3 to 9 Hours After Stroke Onset , 2006, Stroke.
[5] Eric E. Smith,et al. Poor Outcomes in Patients Who Do Not Receive Intravenous Tissue Plasminogen Activator Because of Mild or Improving Ischemic Stroke , 2005, Stroke.
[6] K Yaffe,et al. Frontotemporal dementia progresses to death faster than Alzheimer disease , 2005, Neurology.
[7] Robert Adams,et al. Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. , 2005, Stroke.
[8] J. Martí-Fàbregas,et al. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke , 2005, Neurology.
[9] M. Hammer,et al. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke. , 2004, Archives of neurology.
[10] A. Demchuk,et al. Mild Neurological Symptoms Despite Middle Cerebral Artery Occlusion , 2004, Stroke.
[11] R. Grubb,et al. Guidelines for the Early Management of Patients With Ischemic Stroke: A Scientific Statement From the Stroke Council of the American Stroke Association , 2003, Stroke.
[12] À. Rovira,et al. Prediction of Early Neurological Deterioration Using Diffusion- and Perfusion-Weighted Imaging in Hyperacute Middle Cerebral Artery Ischemic Stroke , 2002, Stroke.
[13] G. Schroth,et al. Intra-Arterial Thrombolysis in 100 Patients With Acute Stroke Due to Middle Cerebral Artery Occlusion , 2002, Stroke.
[14] G Schlaug,et al. Why are stroke patients excluded from tPA therapy? An analysis of patient eligibility , 2001, Neurology.
[15] P. Akins,et al. Intra-arterial prourokinase for acute ischemic stroke. , 2000, JAMA.
[16] A. Alexandrov,et al. Deterioration following spontaneous improvement : sonographic findings in patients with acutely resolving symptoms of cerebral ischemia. , 2000, Stroke.
[17] R. Higashida,et al. Intra-arterial Prourokinase for Acute Ischemic Stroke: The PROACT II Study: A Randomized Controlled Trial , 1999 .
[18] D. Toni,et al. Early spontaneous improvement and deterioration of ischemic stroke patients. A serial study with transcranial Doppler ultrasonography. , 1998, Stroke.
[19] J. Grotta,et al. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. , 1998, Stroke.
[20] L Bozzao,et al. Acute stroke: usefulness of early CT findings before thrombolytic therapy. , 1997, Radiology.
[21] Joseph P. Broderick,et al. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .
[22] David Lee Gordon,et al. Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.
[23] R. Bloch,et al. Interobserver agreement for the assessment of handicap in stroke patients. , 1988, Stroke.